US and Mexico Schedule Three Rounds of Bilateral Trade Talks Excluding Canada Kazatomprom Reports 17 Production Increase in Third Quarter Bolstering Uranium Supply Trumps 750M Trading Disclosure Dwarfs Pelosis 59M Amid Ethics Scrutiny Coal India OFS Opens for Retail Investors at 11 Discount Key Details GitHub Outages Threaten Microsofts AI Coding Edge as Competition Surges AI Mania Drives BubbleLike Concentration in SP 500 Analysts Warn NFE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises 575 SLMBP Q1 2026 Earnings Preferred Stock Series B Results Driven by Strong EPS Surprise EXTR Q1 2026 Earnings EPS Surpasses Estimates Shares Rally Over 7 APWC Q3 1997 Earnings Missed Estimates Amid Operational Challenges ONEOK Q1 2026 Earnings Small EPS Beat Drives Modest Share Gain RES Q1 2026 Earnings EPS Beats Estimates by 1858 Amid Broader Market Headwinds Innospec Inc IOSP Holds Steady Near 82 Amid Low Volatility Nu Holdings NU Holds Steady at 1305 Navigating Support and Resistance in a Flat Session Afya Limited AFYA Faces Modest Decline Amid Consolidation Near Key Levels Mineralys Therapeutics MLYS Edges Lower as Tight Trading Range Persists ING Group Holds Steady at 3123 as European Bank Sector Faces Mixed Signals MRK Q1 2026 Earnings EPS Beats Estimates Despite Net Loss Shares Rise Guzman y Gomez Shares Surge After FastFood Chain Exits US Market to Focus on Australian Operations Pokmon Card Market Surges on Nostalgia and Speculation A New Asset Class Emerges AList Celebrities Honor Stephen Colberts Final Late Show with First Amendment Tribute Implications for CBS Network Champion Homes SKY Q1 2026 Earnings EPS Beats Estimates by 124 as Housing Market Headwinds Persist IE Q1 2026 Earnings EPS Misses Estimates Widely as Exploration Continues South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest ZM Q1 2026 Earnings Strong EPS Beat Amid Revenue Discrepancy Stock Dips Under Armour UAA Bounces from Support Can the Uptrend Hold Keurig Dr Pepper KDP Q1 2026 Earnings EPS Tops Estimates as Cost Controls and Innovation Drive Performance BOLT Q1 2026 Earnings EPS Misses Estimates on Higher RD Costs Stock Edges Up Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage MRBK Q1 2026 Earnings EPS Misses Estimates Stock Declines Modestly Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 Select Medical Q1 2026 Earnings EPS Misses Estimates by 2398 Amid Operational Headwinds SWBI Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty